123 related articles for article (PubMed ID: 10378889)
21. Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias.
Hayette S; Thomas X; Bertrand Y; Tigaud I; Callanan M; Thiebaut A; Charrin C; Archimbaud E; Magaud JP; Rimokh R
Leukemia; 1997 Oct; 11(10):1696-9. PubMed ID: 9324291
[TBL] [Abstract][Full Text] [Related]
22. Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features.
Fizzotti M; Cimino G; Pisegna S; Alimena G; Quartarone C; Mandelli F; Pelicci PG; Lo Coco F
Blood; 1995 May; 85(10):2685-90. PubMed ID: 7742527
[TBL] [Abstract][Full Text] [Related]
23. Abnormalities of tumor suppressor genes P16 and P15 in primary maxillofacial squamous cell carcinomas.
Zhao Y; Zhang S; Fu B; Xiao C
Cancer Genet Cytogenet; 1999 Jul; 112(1):26-33. PubMed ID: 10432931
[TBL] [Abstract][Full Text] [Related]
24. p53 gene mutation and loss of heterozygosity are associated with increased risk of disease progression in adult T cell leukemia.
Nishimura S; Asou N; Suzushima H; Okubo T; Fujimoto T; Osato M; Yamasaki H; Lisha L; Takatsuki K
Leukemia; 1995 Apr; 9(4):598-604. PubMed ID: 7723391
[TBL] [Abstract][Full Text] [Related]
25. Inactivation of tumor suppressor genes p15(INK4b) and p16(INK4a) in primary cutaneous B cell lymphoma.
Child FJ; Scarisbrick JJ; Calonje E; Orchard G; Russell-Jones R; Whittaker SJ
J Invest Dermatol; 2002 Jun; 118(6):941-8. PubMed ID: 12060387
[TBL] [Abstract][Full Text] [Related]
26. Lack of evidence for mutations or deletions in the CDKN2A/p16 and CDKN2B/p15 genes of Brazilian neuroblastoma patients.
Bassi CL; Martelli L; Cipolotti R; Scrideli CA; Defávery R; Tone LG
Braz J Med Biol Res; 2004 Nov; 37(11):1683-7. PubMed ID: 15517085
[TBL] [Abstract][Full Text] [Related]
27. Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas.
Bisogna M; Calvano JE; Ho GH; Orlow I; Cordón-Cardó C; Borgen PI; Van Zee KJ
Cancer Genet Cytogenet; 2001 Mar; 125(2):131-8. PubMed ID: 11369056
[TBL] [Abstract][Full Text] [Related]
28. A comparative study of glioma cell lines for p16, p15, p53 and p21 gene alterations.
Zhang S; Endo S; Koga H; Ichikawa T; Feng X; Onda K; Washiyama K; Kumanishi T
Jpn J Cancer Res; 1996 Sep; 87(9):900-7. PubMed ID: 8878451
[TBL] [Abstract][Full Text] [Related]
29. Variable expression of p16 protein in patients with acute myeloid leukemia without gross rearrangements at the DNA level.
Jamal R; Thomas NS; Gale RE; Linch DC
Leukemia; 1996 Apr; 10(4):629-36. PubMed ID: 8618439
[TBL] [Abstract][Full Text] [Related]
30. Deletion or lack of expression of CDKN2 (CDK4I/MTS1/INK4A) and MTS2 (INK4B) in acute lymphoblastic leukemia cell lines reflects the phenotype of the uncultured primary leukemia cells.
Jagasia AA; Sher DA; Le Moine PJ; Kim DH; Moldwin RL; Smith SD; Diaz MO
Leukemia; 1996 Apr; 10(4):624-8. PubMed ID: 8618438
[TBL] [Abstract][Full Text] [Related]
31. Homozygous deletion of the p16/MTS-1/CDKN2 gene in malignant gliomas is infrequent among Japanese patients.
Mochizuki S; Iwadate Y; Namba H; Yoshida Y; Yamaura A; Sakiyama S; Tagawa M
Int J Oncol; 1999 Nov; 15(5):983-9. PubMed ID: 10536183
[TBL] [Abstract][Full Text] [Related]
32. The methylthioadenosine phosphorylase gene is frequently co-deleted with the p16INK4a gene in acute type adult T-cell leukemia.
Hori Y; Hori H; Yamada Y; Carrera CJ; Tomonaga M; Kamihira S; Carson DA; Nobori T
Int J Cancer; 1998 Jan; 75(1):51-6. PubMed ID: 9426690
[TBL] [Abstract][Full Text] [Related]
33. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
Fujishita T; Mizushima Y; Kashii T; Kobayashi M
Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367
[TBL] [Abstract][Full Text] [Related]
34. Adult T-cell leukemia: structures and expression of the p53 gene.
Sugito S; Yamato K; Sameshima Y; Yokota J; Yano S; Miyoshi I
Int J Cancer; 1991 Dec; 49(6):880-5. PubMed ID: 1959992
[TBL] [Abstract][Full Text] [Related]
35. Detection of methylthioadenosine phosphorylase (MTAP) and p16 gene deletion in T cell acute lymphoblastic leukemia by real-time quantitative PCR assay.
M'soka TJ; Nishioka J; Taga A; Kato K; Kawasaki H; Yamada Y; Yu A; Komada Y; Nobori T
Leukemia; 2000 May; 14(5):935-40. PubMed ID: 10803528
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage.
Nakagawa K; Conrad NK; Williams JP; Johnson BE; Kelley MJ
Oncogene; 1995 Nov; 11(9):1843-51. PubMed ID: 7478613
[TBL] [Abstract][Full Text] [Related]
37. Frequent deletion and 5' CpG island methylation of the p16 gene in primary malignant lymphoma of the brain.
Zhang SJ; Endo S; Ichikawa T; Washiyama K; Kumanishi T
Cancer Res; 1998 Mar; 58(6):1231-7. PubMed ID: 9515810
[TBL] [Abstract][Full Text] [Related]
38. Autocrine and/or paracrine growth of adult T-cell leukaemia tumour cells by interleukin 15.
Kukita T; Arima N; Matsushita K; Arimura K; Ohtsubo H; Sakaki Y; Fujiwara H; Ozaki A; Matsumoto T; Tei C
Br J Haematol; 2002 Nov; 119(2):467-74. PubMed ID: 12406087
[TBL] [Abstract][Full Text] [Related]
39. Absence of p16 and p27 gene rearrangements and mutations in de novo myelodysplastic syndromes.
Papageorgiou SG; Pappa V; Papageorgiou E; Tsirigotis P; Kontsioti F; Panani A; Dervenoulas J; Economopoulos T
Eur J Haematol; 2005 Sep; 75(3):193-8. PubMed ID: 16104874
[TBL] [Abstract][Full Text] [Related]
40. Mutational and methylation analysis of the cyclin-dependent kinase 4 inhibitor (p16INK4A) gene in chronic lymphocytic leukemia.
Tsirigotis P; Pappa V; Labropoulos S; Papageorgiou S; Kontsioti F; Dervenoulas J; Papageorgiou E; Panani A; Mantzios G; Economopoulos T; Raptis S
Eur J Haematol; 2006 Mar; 76(3):230-6. PubMed ID: 16412137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]